LABEST 2021 - DAY THREE

 LABEST DAY 3 - Thursday, May 27th

11:00AM - 11:30AM KEYNOTE ADDRESS  COVID-19 and BEYOND - How to stop a pandemic before it starts

Anne Rimoin, Professor, Department of Epidemiology, UCLA Fielding School of Public Health

11:30AM - 11:35AM  OPENING REMARKS                                                        

William E. (Bill) Mitchell, Founding Partner, Sequel Venture Partners, LLC and Chairman, TDC Board

11:35AM - 12:30PM - HOSPITAL CEOS SHARING INNOVATIONS - KITE, A GILEAD COMPANY AUDITORIUM

CEOs of Los Angeles' hospital systems will share their best practices and resulting innovations to address the COVID-19 pandemic and how their collaborative efforts will shape the future of hospital systems and the health of Los Angeles County.

	Moderator: Judy Fortin, Executive Director of Communication, UCLA Health & David Geffen School of Medicine
	Johnese Spisso, President, UCLA Health, UCLA Hospital System
	Jeff Smith, EVP and COO, Cedars Sinai Health System
	Rod Hanners, CEO, Keck Medicine of USC
	Elaine Batchlor, CEO, MLK Community Healthcare

12:30PM - 1:15PM - EMERGING THERAPEUTICS IN NEUROSCIENCE - AMGEN AUDITORIUM

Recent advances in neuroscience will be discussed by a panel of experts seeking to impact these frequently unmet medical needs.

	Moderator: Robert Pacifici, Chief Scientific Officer, CHDI Foundation and TDG Board Member
	Dan Geschwind, Gordon and Virginia McDonald Distinguished Professor, Neurology, Psychiatry & Human Genetics, UCLA
	Linda Liau, Chair, UCLA Department of Neurosurgery
	Richard Ransohoff, Partner, Third Rock Ventures
	Greg Rippon, Vice President, Chief Medical Officer, Neurology, Genentech
	Viviana Gradinaru, Professor of Neuroscience and Biological Engineering, Caltech

1:00PM - 1:45PM - SCALING GENE & CELL THERAPIES TO REACH MORE PATIENTS GLOBALLY - KITE, A GILEAD COMPANY AUDITORIUM

Due to a complex, multi-step treatment journey, there are numerous logistical challenges when it comes to expanding the reach of cell and gene therapies. How can we leverage bio manufacturing speed and scale to unlock the potential of cell and gene therapies and ensure they can get to the patients who need them?

	Moderator: Gregory Theyel, Director, Biomedical Manufacturing Network
	Chuck Calderaro, Global Head of Technical Operations, Kite, A Gilead Company
	Allison Moore, Chief Technical Officer, Allogene Therapeutics
	Joe Gold, Manufacturing Director, Center for Biomedicine at Beckman Research Institute, City of Hope
	Robert Deans, Chief Scientific Officer, Synthego

1:30PM - 2:15PM - AMGEN VENTURES AND BUSINESS DEVELOPMENT IN LOS ANGELES - AMGEN AUDITORIUM

How much bioscience business development is really happening in Los Angeles?

	Moderator: Rajit Malhotra, Executive Chairman, Ampersand Biopharmaceuticals, TDG Board Member
	Jessica Droge, Vice President, Business Development, AMGEN
	Rachna Khosla, Vice President, Business Development, AMGEN
	Janis Naeve, Executive Director, AMGEN
	Casey Capparelli, Executive Director, Strategy, AMGEN
	Carlyn Crisostomo, Executive Director, Technology, Strategy & Innovation, AMGEN